Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

AVAC for atopic dermatitis completes phase I testing in children

March 7, 2003

FDA accepts Xoma's BLA for Raptiva

March 5, 2003

Abbott expands Humira development into psoriasis and psoriatic arthritis

March 5, 2003

Serono seeks European approval for Raptiva for psoriasis

Feb. 28, 2003

Metvix PDT recommended for approval in Australia

Feb. 27, 2003

MorphoSys and Boehringer Ingelheim collaborate on therapeutic antibodies

Feb. 27, 2003

Label for Botox widened in Europe

Feb. 27, 2003

Promising results reported for Targretin in chronic severe hand dermatitis

Feb. 25, 2003

Delay announced in European approval for Amevive

Feb. 21, 2003

Pharmacodynamics and pharmacokinetics of infliximab in psoriatic patients

Feb. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...